The placenta in Beckwith-Wiedemann syndrome: Genotype-phenotype associations, excessive extravillous trophoblast and placental mesenchymal dysplasia

Pathology

Volumn 44, Issue 6, 2012, Pages 519-527

  Armes, Jane E ^a   McGown, Ivan ^a   Williams, Mark ^a   Broomfield, Amy ^a   Gough, Karen ^b   Lehane, Fiona ^a   Lourie, Rohan ^a  

^a Departments of Anatomical Molecular   (Australia)

^b MATER HOSPITAL   (Australia)

Author keywords

Beckwith Wiedemann syndrome; DNA genotyping; IGF2; Placental mesenchymal dysplasia

Indexed keywords

EID: 84866950339     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e3283559c94     Document Type: Article

References (19)

1. Robinson WP, Lauzon JL, Innes AM, et al. Origin and outcome of pregnancies affected by androgenetic/biparental chimerism. Hum Reprod 2007; 22: 1114-22.
2. Surti U, Hill LM, Dunn J, et al. Twin pregnancy with a chimeric androgenetic and biparental placenta in one twin displaying placental mesenchymal dysplasia phenotype. Prenat Diagn 2005; 25: 1048-56.
3. Kaiser-Rogers KA, McFadden DE, Livasy CA, et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 2006; 43: 187-92.
4. Cohen MC, Roper EC, Sebire NJ, et al. Placental mesenchymal dysplasia associated with fetal aneuploidy. Prenat Diagn 2005; 25: 187-92.
5. Shuman C, Beckwith JB, Smith AC, et al. Beckwith-Wiedemann syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. GeneReviews [Internet]. Seattle: University of Washington, 1993-2000.
6. Bliek J, Maas SM, Ruijter JM, et al. Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS. Hum Mol Genet 2001; 10: 467-76.
7. Enklaar T, Zabel BU, Prawitt D. Beckwith-Wiedemann syndrome: multiple molecular mechanisms. Expert Rev Mol Med 2006; 8: 1-19.
8. Jauniaux E, Nicolaides KH, Hustin J. Perinatal features associated with placental mesenchymal dysplasia. Placenta 1997; 18: 701-6.
9. Shapiro LR, Duncan PA, Davidian MM, et al. The placenta in familial Beckwith-Wiedemann syndrome. Birth Defects Orig Artic Ser 1982; 18: 203-6.
10. Takayama M, Soma H, Yaguchi S, et al. Abnormally large placenta associated with Beckwith-Wiedemann syndrome. Gynecol Obstet Invest 1986; 22: 165-8.
11. Stanek J, Khalequzzaman M. Placental mesenchymal dysplasia (PMD) with mosaic triploidy and chorangiomas presenting as a partial hydatidiform mole (PHM). Virchows Arch 2010; 457: 218.
12. Korgun ET, Celik-Ozenci C, Acar N, et al. Location of cell cycle regulators cyclin B1, cyclin A, PCNA, Ki67 and cell cycle inhibitors p21, p27 and p57 in human first trimester placenta and deciduas. Histochem Cell Biol 2006; 125: 615-24.
13. Frank HG, Malekzadeh F, Kertschanska S, et al. Immunohistochemistry of two different types of placental fibrinoid. Acta Anat (Basel) 1994; 150: 55-68.
14. Jun S-Y, Ro JY, Kim K-R. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Histopathology 2003; 43: 17-25.
15. Hiden U, Glitzner E, Hartmann M, Desoye G. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J Anat 2009; 215: 60-8.
16. Hoffner L,Dunn J, Esposito N, et al. P57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions. Hum Pathol 2008; 39: 63-72.
17. Umazume T, Kataoka S, Kamamuta K, et al. Placental mesenchymal dysplasia, a case of intrauterine sudden death of fetus with rupture of cirsoid periumbilical chorionic vessels. Diagn Pathol 2011; 6: 38.
18. Arizawa M, Nakayama M. Suspected involvement of the X chromosome in placental mesenchymal dysplasia. Congenital Anom 2002; 42: 309-17.
19. Surti U, Hoffner L, Kolthoff M, et al. Persistent gestational trophoblastic disease after an androgenetic/biparental fetal chimera: a case report and review. Int J Gynecol Pathol 2006; 25: 366-72.